The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
October 8th 2024
An interim analysis of the PRO-SPIRIT study compared outcomes at 3 months after starting new treatments for psoriatic arthritis.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
New NIH Network Will Support Development of Novel Treatments for Rheumatoid Arthritis and Lupus
September 24th 2014The Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus Network is a public-private partnership designed to accelerate research into more effective diagnostic and treatment approaches for these autoimmune diseases.
Lupus Plays Unlikely Role as Ally in Cancer Fight
Patients diagnosed with lupus know only too well that the cells in their body are working against them as the condition progresses. Now, researchers at Yale University say they have found a way to take those same cells and use them to help cancer patients.
Rheumatology Criteria Ignore Neurological Presenting Symptoms
September 22nd 2014Neurological symptoms may be the presenting feature in lupus, sarcoidosis, vasculitis, and other rheumatic diseases, notes this review. Treatment may also cause neurological side effects including demyelination, tremor, and psychosis.
Do Patients Diagnosed with Fibromyalgia Receive Guideline-compliant Treatment?
September 21st 2014Study results show that patients diagnosed with fibromyalgia often discontinue treatment. Those that do not frequently augment their initial treatment regimen with one or more additional medications, including some that are not recommended by current guidelines.
Chronic Pain Is the Most Common Reason for Dietary Supplement Use
September 21st 2014Knowledge of dietary supplement properties, uses, and contraindications is highly relevant to any health care practitioner that treats patients with chronic pain. Data shows that the top four reasons for supplement use are back pain, neck pain, joint pain, and arthritis.
Behind the High Pneumonia Risk in Lupus: Innate Defect?
September 18th 2014Confirming the high pneumonia risk in lupus patients, researchers in Spain have found that it may precede the onset of the immune disorder. Their biological studies suggest that a particular underlying immune abnormality may explain both.
Cartilage and its Role in Rheumatoid Arthritis
As any athlete or active person knows, the health of the cartilage in the knee can make the difference between comfortably moving around and pain that can stop you in your tracks. Researchers in Australia have recently discovered a stronger than expected link between knee cartilage and rheumatoid arthritis.
Two RCTs in Rheumatology Look Different As Background Changes
September 15th 2014Reanalyzing randomized trials by different methods, including one about scleroderma and another involving fibrositis, has changed their conclusions. The authors of this analysis argue for more openness when reporting trial data.
Which Biologic Therapy Is the Best Choice for Patients With Rheumatoid Arthritis?
September 15th 2014The choice of an appropriate disease-modifying antirheumatic drug (DMARD) is complicated by the availability of several agents and the lack of comparative effectiveness studies. Until recently, the scientific consensus did not favor any agent over another as the most appropriate initial biologic DMARD for patients with rheumatoid arthritis (RA).
Found: Why B Cells Attack DNA in Lupus
September 12th 2014A large international team has honed in on the fragment of the complement receptor that decreases the risk for lupus. This has allowed them to offer a plausible explanation for why B cells target certain regions of double-stranded DNA after encountering debris from dying cells.
The Multifaceted Pathogenesis of Rheumatoid Arthritis
September 12th 2014Although not completely understood, the pathogenesis of rheumatoid arthritis is thought to involve an external trigger (eg, trauma, cigarette smoke, infection) that induces an autoimmune reaction, resulting in synovial hypertrophy and chronic joint inflammation in persons who are genetically susceptible.
Insights from Mouse Research Point to Better Lupus Drugs
September 9th 2014Studies of genes shared by lupus patients and mice bred to have similar disorders point to the specific pathways of immune self-destruction. Many more targeted treatments than steroids and hydroxychloroquine should follow, says a review of this research.